| First Author | Zhao W | Year | 2020 |
| Journal | Sci Rep | Volume | 10 |
| Issue | 1 | Pages | 7641 |
| PubMed ID | 32376831 | Mgi Jnum | J:292300 |
| Mgi Id | MGI:6447183 | Doi | 10.1038/s41598-020-63393-x |
| Citation | Zhao W, et al. (2020) The Lipocalin2 Gene is Regulated in Mammary Epithelial Cells by NFkappaB and C/EBP In Response to Mycoplasma. Sci Rep 10(1):7641 |
| abstractText | Lcn2 gene expression increases in response to cell stress signals, particularly in cells involved in the innate immune response. Human Lcn2 (NGAL) is increased in the blood and tissues in response to many stressors including microbial infection and in response to LPS in myeloid and epithelial cells. Here we extend the microbial activators of Lcn2 to mycoplasma and describe studies in which the mechanism of Lcn2 gene regulation by MALP-2 and mycoplasma infection was investigated in mouse mammary epithelial cells. As for the LPS response of myeloid cells, Lcn2 expression in epithelial cells is preceded by increased TNFalpha, IL-6 and IkappaBzeta expression and selective reduction of IkappaBzeta reduces Lcn2 promoter activity. Lcn2 promoter activation remains elevated well beyond the period of exposure to MALP-2 and is persistently elevated in mycoplasma infected cells. Activation of either the human or the mouse Lcn2 promoter requires both NFkappaB and C/EBP for activation. Thus, Lcn2 is strongly and enduringly activated by mycoplasma components that stimulate the innate immune response with the same basic regulatory mechanism for the human and mouse genes. |
